Igarashi N
Nihon Jinzo Gakkai Shi. 1989 Apr;31(4):367-77.
The effects of nifedipine (NIF) on blood pressure and renal function were examined in control spontaneously hypertensive rats (SHR) (group A), SHR with moderate renal dysfunction (group B), and those with severe renal dysfunction (group C). The hypotensive effect of NIF administration was greater in SHR with severe renal dysfunction, and this might relate with pharmacokinetics of NIF, decreased sensitivity of baroreflex and low plasma renin activity in SHR with reduced renal function. When mean arterial blood pressure (MAP) was reduced by about 30% in these three groups, the baseline renal function was maintained and natriuresis was observed in group A and B, whereas the renal function and urine volume decreased transiently, and urinary sodium excretion tended to decrease in group C. In hypertensive patients with normal renal function (group I), moderate renal dysfunction (group II), and severe renal dysfunction (group III), 5 or 10 mg NIF was orally administered. In these three groups, MAP was reduced by about 20%. In group I, glomerular filtration rate tended to increase, renal plasma flow increased and natriuresis was observed. In group II and III, renal function didn't decrease with few exception, but when MAP was reduced by about 30%, renal function decreased in three of five cases. Also on long-term administration of NIF in hypertensive patients, renal function improved. The results suggests that NIF by single administration or long-term administration is effective on hypertensive patients with renal dysfunction, but we should be cautious to decide the dose of NIF and the rate of blood pressure reduction.
在正常自发性高血压大鼠(SHR)(A组)、中度肾功能不全的SHR(B组)和重度肾功能不全的SHR(C组)中研究了硝苯地平(NIF)对血压和肾功能的影响。NIF给药的降压作用在重度肾功能不全的SHR中更大,这可能与NIF的药代动力学、压力感受器反射敏感性降低以及肾功能降低的SHR中血浆肾素活性低有关。当这三组的平均动脉血压(MAP)降低约30%时,A组和B组的基线肾功能得以维持并观察到利钠作用,而C组的肾功能和尿量短暂下降,尿钠排泄趋于减少。在肾功能正常的高血压患者(I组)、中度肾功能不全患者(II组)和重度肾功能不全患者(III组)中,口服5或10 mg NIF。在这三组中,MAP降低约20%。在I组中,肾小球滤过率趋于增加,肾血浆流量增加并观察到利钠作用。在II组和III组中,肾功能除少数例外没有下降,但当MAP降低约30%时,五例中有三例肾功能下降。此外,在高血压患者中长期服用NIF时,肾功能得到改善。结果表明,单次给药或长期给药的NIF对肾功能不全的高血压患者有效,但我们在确定NIF剂量和血压降低率时应谨慎。